Articles Related to cervix
Assessment of Changes in Clinical Management of Cervical Cancer Patients in Light of New Staging Criteria
Objective: To assess the changes in the Current clinical management of cancer cervix patients as the new staging considers
radiological and pathological criteria for cervical cancer staging.
Methods: This retrospective study Retrospective collection of the Data from the medical records.
Results: Five hundred and nine Patients were registered for cervical cancer from Jan 2019 to December 2021. The average
age of patients treated was 53yrs. The patients' age distribution ( Table 2 ) was Less than one percent of patients below 30yrs,
31.4 percent, and 40.6 percent were in the 50 to 60 yrs range
A Screening Study of Cervical Cancer Using Pap Smear Test in Outpatient Clinic of Must University Hospital
Despite the well-established importance of early cervical cancer detection, there are no clear data about the prevalence of cervical intraepithelial lesions among Egyptian population due to lack of screening programs. Thus, we conducted this study in order to assess the prevalence of inflammatory, premalignant and malignant cervical lesions among Egyptian population using Pap smear test.
A Laparoscopic Assisted Minilaparotomy Hysterectomy approach for Very Large Fibroid Uteri of more than 1000 grams – A Preliminary Study
Minilaparotomy has been used for tubal sterilization for decades. It became a new surgical idea described by some who performed minilaparotomy hysterectomy and achieved outcomes that were less invasive than those of traditional open laparotomy. Pelosi and Pelosi 2004 reported a minilaparotomy procedure in patients in whom vaginal hysterectomy was considered contraindicated. Their procedure offered a safe alternative with minimal access and good outcome.
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.